CDK5-IN-4

Overview

CDK5-IN-4 (compound 4) is a potent multikinase type-II inhibitor targeting CDK5 , with an IC 50 of 9.8 μM. CDK5-IN-4 also inhibits GSK-3α , GSK-3β , CDK9 , and CDK2 , with IC 50 values of 0.98, 4.00, 1.76, and 6.24 μM, respectively. CDK5-IN-4 can be used for glioblastoma research.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > CDK | Products > Signaling Pathways > GSK-3

Product Information

• Catalog No.: HY-161595
• CAS No.: 1212711-91-5
• Molecular Formula: C24H24FN5O3
• Molecular Weight: 449.48
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source